S H Factor1, Y Lo, E Schoenbaum, R S Klein. 1. Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 10029, USA. stephanie.factor@mssm.edu
Abstract
OBJECTIVES: Antiretroviral (ARV) therapy has prolonged the life expectancy of HIV-infected persons, increasing their risk of age-associated diseases, including atherosclerosis (AS). Decreased risk of AS has been associated with the prevention and control of hypertension (HTN). We conducted a cohort study of perimenopausal women and older men with or at risk of HIV infection to identify risk factors for incident HTN. METHODS: Standardized interviews, physical examinations, and laboratory examinations were scheduled at 6-month intervals. Interview data included demographics, medical, family, sexual behaviour and drug use histories, and physical activity. RESULTS: There were 330 women and 329 men eligible for inclusion in the study; 27% and 35% of participants developed HTN during a median follow-up period of 1080 and 1071 days, respectively. In gender-stratified analysis, adjusting for traditional HTN risk factors (age, race, body mass index, smoking, diabetes, family history of HTN, alcohol dependence, physical activity and high cholesterol), HIV infection was not associated with incident HTN in women [hazard ratio (HR) 1.31; 95% confidence interval (CI) 0.56, 3.06] or men (HR 1.67; 95% CI 0.75, 3.74). Among HIV-infected women, although exposure to ARVs was not significantly associated with incident HTN (HR 0.72; 95% CI 0.26, 1.99), CD4 T-cell count was positively associated with incident HTN (HR 1.15 per 100 cells/μL; 95% CI 1.03, 1.28). Among physically active HIV-infected men, exposure to ARVs was negatively associated with incident HTN (HR 0.15; 95% CI 0.03, 0.78). CONCLUSIONS: HIV infection was not associated with incident HTN in older men or women. This study provides additional evidence supporting a causal relationship between immune function and incident HTN, which warrants further study.
OBJECTIVES: Antiretroviral (ARV) therapy has prolonged the life expectancy of HIV-infectedpersons, increasing their risk of age-associated diseases, including atherosclerosis (AS). Decreased risk of AS has been associated with the prevention and control of hypertension (HTN). We conducted a cohort study of perimenopausal women and older men with or at risk of HIV infection to identify risk factors for incident HTN. METHODS: Standardized interviews, physical examinations, and laboratory examinations were scheduled at 6-month intervals. Interview data included demographics, medical, family, sexual behaviour and drug use histories, and physical activity. RESULTS: There were 330 women and 329 men eligible for inclusion in the study; 27% and 35% of participants developed HTN during a median follow-up period of 1080 and 1071 days, respectively. In gender-stratified analysis, adjusting for traditional HTN risk factors (age, race, body mass index, smoking, diabetes, family history of HTN, alcohol dependence, physical activity and high cholesterol), HIV infection was not associated with incident HTN in women [hazard ratio (HR) 1.31; 95% confidence interval (CI) 0.56, 3.06] or men (HR 1.67; 95% CI 0.75, 3.74). Among HIV-infectedwomen, although exposure to ARVs was not significantly associated with incident HTN (HR 0.72; 95% CI 0.26, 1.99), CD4 T-cell count was positively associated with incident HTN (HR 1.15 per 100 cells/μL; 95% CI 1.03, 1.28). Among physically active HIV-infectedmen, exposure to ARVs was negatively associated with incident HTN (HR 0.15; 95% CI 0.03, 0.78). CONCLUSIONS:HIV infection was not associated with incident HTN in older men or women. This study provides additional evidence supporting a causal relationship between immune function and incident HTN, which warrants further study.
Authors: Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton Journal: J Infect Dis Date: 2010-06-15 Impact factor: 5.226
Authors: Phyllis C Tien; Andy I Choi; Andrew R Zolopa; Constance Benson; Russell Tracy; Rebecca Scherzer; Peter Bacchetti; Michael Shlipak; Carl Grunfeld Journal: J Acquir Immune Defic Syndr Date: 2010-11 Impact factor: 3.731
Authors: Alexandra Mangili; Joseph F Polak; Lien A Quach; Jul Gerrior; Christine A Wanke Journal: Atherosclerosis Date: 2010-11-17 Impact factor: 5.162
Authors: Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek Journal: J Infect Dis Date: 2011-01-20 Impact factor: 5.226
Authors: Shenghan Lai; Hong Lai; David D Celentano; David Vlahov; Shiquan Ren; Joseph Margolick; Joao A C Lima; John G Bartlett Journal: AIDS Patient Care STDS Date: 2003-05 Impact factor: 5.078
Authors: Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison Journal: Hypertension Date: 2009-12-28 Impact factor: 10.190
Authors: Robert C Kaplan; Elizabeth Sinclair; Alan L Landay; Nell Lurain; A Richey Sharrett; Stephen J Gange; Xiaonan Xue; Peter Hunt; Roksana Karim; David M Kern; Howard N Hodis; Steven G Deeks Journal: J Infect Dis Date: 2011-01-10 Impact factor: 5.226
Authors: Yunan Xu; Xinguang Chen; Akemi Wijayabahu; Zhi Zhou; Bin Yu; Emma C Spencer; Robert L Cook Journal: Curr HIV Res Date: 2020 Impact factor: 1.581
Authors: Cherise Wong; Stephen J Gange; Kate Buchacz; Richard D Moore; Amy C Justice; Michael A Horberg; M John Gill; John R Koethe; Peter F Rebeiro; Michael J Silverberg; Frank J Palella; Pragna Patel; Mari M Kitahata; Heidi M Crane; Alison G Abraham; Hasina Samji; Sonia Napravnik; Tareq Ahmed; Jennifer E Thorne; Ronald J Bosch; Angel M Mayor; Keri N Althoff Journal: Clin Infect Dis Date: 2017-02-15 Impact factor: 9.079